Open Access

Alginate–gelatin hydrogel supplemented with platelet concentrates can be used as bioinks for scaffold printing

Tuyet Thi Vi Le

Tuyet Thi Vi Le

  • Department of Physiology and Animal Biotechnology, Biology and Biotechnology Faculty, University of ScienceHo Chi Minh City, Vietnam
  • Laboratory of Tissue Engineering and Biomedical Materials, University of ScienceHo Chi Minh City, Vietnam
  • Vietnam National UniversityHo Chi Minh City, Vietnam
Search for this author on
Sciendo|Google Scholar
Le, Tuyet Thi Vi
, 
Nghia Thi Hieu Phan

Nghia Thi Hieu Phan

  • Department of Physiology and Animal Biotechnology, Biology and Biotechnology Faculty, University of ScienceHo Chi Minh City, Vietnam
  • Laboratory of Tissue Engineering and Biomedical Materials, University of ScienceHo Chi Minh City, Vietnam
  • Vietnam National UniversityHo Chi Minh City, Vietnam
Search for this author on
Sciendo|Google Scholar
Phan, Nghia Thi Hieu
 and 
Ha Le Bao Tran

Ha Le Bao Tran

  • Department of Physiology and Animal Biotechnology, Biology and Biotechnology Faculty, University of ScienceHo Chi Minh City, Vietnam
  • Laboratory of Tissue Engineering and Biomedical Materials, University of ScienceHo Chi Minh City, Vietnam
  • Vietnam National UniversityHo Chi Minh City, Vietnam
Search for this author on
Sciendo|Google Scholar
Tran, Ha Le Bao
  
Oct 26, 2023
Alginate–gelatin hydrogel supplemented with platelet concentrates can be used as bioinks for scaffold printing's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Original article
Published Online: Oct 26, 2023
Page range: 222 - 229
DOI: https://doi.org/10.2478/abm-2023-0063
Keywords
© 2023 Tuyet Thi Vi Le et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.

Figure 1.

The sol–gel transition of bioinks over time through inversion test. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.
The sol–gel transition of bioinks over time through inversion test. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.

Figure 2.

The pH of bioinks. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.
The pH of bioinks. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.

Figure 3.

GFs release from scaffolds over time. (A) AGP and AGF scaffolds, (B) Growth factors release. AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; GFs, growth factors; PDGF-AB; platelet-derived GF-AB; VEGF, vascular endothelial GF.
GFs release from scaffolds over time. (A) AGP and AGF scaffolds, (B) Growth factors release. AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; GFs, growth factors; PDGF-AB; platelet-derived GF-AB; VEGF, vascular endothelial GF.

Figure 4.

The RGR of cells in the serum-free extracts. ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.
The RGR of cells in the serum-free extracts. ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.

Figure 5.

The RGR of cells in the serum-containing extracts. ***P < 0.001, ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.
The RGR of cells in the serum-containing extracts. ***P < 0.001, ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, Basic Medical Science, other, Clinical Medicine, Clinical Medicine, other
Journal RSS Feed